By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Radius Health 

950 Winter Street

Waltham  Massachusetts  02451  U.S.A.
Phone: 617-551-4000 Fax: 617-551-4701


Radius is a science-driven biopharmaceutical company focused on developing new therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases.

Radius is committed to the research and development of new therapeutics for the large and underserved osteoporosis market.


October 3, 2003


Founders: John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt and John T. Potts

CEO: Robert Ward

CMO (Medical): Lorraine Fitzpatrick

CFO: Nick Harvey

CSO (Scientific): Gary Hattersley


Please click here for Radius Health job opportunities.


Please click here for clinical trial information.

Key Statistics

Ownership: Public

Web Site: Radius Health
Symbol: RDUS


Company News
Radius Health (RDUS) Presents Positive Data From A Fully Enrolled Ongoing Phase I Study For Investigational Drug Elacestrant (RAD1901) At The 2017 ASCO 6/5/2017 12:51:32 PM
Radius Health (RDUS)'s Osteoporosis Drug Meets All Primary and Secondary Endpoints in Phase III Test 5/25/2017 8:04:52 AM
Radius Health (RDUS) Announces New Employment Inducement Grant 5/16/2017 10:54:00 AM
Radius Health (RDUS) Appoints Pharmaceutical Executive Jose Carmona As Chief Financial Officer 5/15/2017 9:58:40 AM
Radius Health (RDUS) Reports First Quarter 2017 Financial And Operating Results 5/1/2017 11:14:26 AM
FDA Approves Radius Health (RDUS)’s TYMLOS (Abaloparatide), A Bone Building Agent For The Treatment Of Postmenopausal Women With Osteoporosis At High Risk For Fracture 4/28/2017 10:59:14 AM
Radius Health (RDUS) Announces Presentations At Upcoming Conferences And Its Plans To Announce First Quarter Financial Results On May 3, 2017 4/6/2017 11:31:58 AM
Radius Health (RDUS) Release: New Analysis from ACTIVE Showed Consistent Fracture Reductions for Abaloparatide-SC Across Geographies 4/3/2017 1:54:13 PM
Radius Health (RDUS) Falls on PDUFA Extension for Abaloparatide-SC 3/10/2017 8:41:49 AM
Radius Health (RDUS) Reports Fourth Quarter And Full Year 2016 Financial And Operating Results 2/24/2017 8:20:47 AM